产品详情
简单介绍：
Anti-Complement component C9a抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-Complement component C9a抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-Complement component C9a
Cat. Number:
Anti-Complement component C9a抗体KL-11190R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
C9 is a plasma protein synthesized in the liver and monocytes consisting of a single polypeptide chain. C9 is a part Anti-Complement component C9a抗体of the membrane attack complex (MAC), an important component of the immune system. The MAC forms upon complement system activation by invading pathogenic bacteria and consists of the four major complement proteins: C5b, C6, C7 and C8. These complement proteins bind to the outer surface of the plasma membrane of the invading cell. C9 binds to the membrane associated C5b-8 protein, which leads to the circular polymerization of 12-18 C9 molecules. These polymerized C9 molecules form a ring structure in the membrane. Molecules can then diffuse freely through this transmembrane channel, causing cell lysis and destruction of the invading bacterial cell.
Also known as:
C9a, C9 deficiency; Anti-Complement component C9a抗体C9a; C9 deficiency with dermatomyositis; CO9_HUMAN; Complement component 9; Complement component 9 deficiency; Complement component C9a; Complement component C9a; C9.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Complement component C9a.
●
Predicted Molecular Anti-Complement component C9a抗体Weight: 28/61kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-Complement component C9a抗体
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl141Hu03 尿激酶型纤溶酶原激活因子受体(ukl)多克隆抗体 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl235Ra02 补体1抑制因子(C1INH)多克隆抗体 Polyclonal Antibody to Complement 1 Inhibitor (C1INH)
kl262Hu03 转铁蛋白受体2(TFR2)多克隆抗体 Polyclonal Antibody to Transferrin Receptor 2 (TFR2)
kl449Hu02 胱天蛋白酶7(CASP7)多克隆抗体 Polyclonal Antibody to Caskle 7 (CASP7)
kl537Hu02 神经元特异性烯醇化酶(NSE)多克隆抗体 Polyclonal Antibody to Enolase, Neuron Specific (NSE)
kl537Mu02 神经元特异性烯醇化酶(NSE)多克隆抗体 Polyclonal Antibody to Enolase, Neuron Specific (NSE)
kl547Mu02 血管细胞粘附分子1(VCAM1)多克隆抗体 Polyclonal Antibody to Vascular Cell Adhesion Molecule 1 (VCAM1)
kl556Ra02 角蛋白7(KRT7)多克隆抗体 Polyclonal Antibody to Keratin 7 (KRT7)
kl557Mu01 甲状腺过氧化物酶(TPO)多克隆抗体 Polyclonal Antibody to Thyroid Peroxidase (TPO)
kl561Hu03 白血病抑制因子受体(LIFR)多克隆抗体 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl561Mu02 白血病抑制因子受体(LIFR)多克隆抗体 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl561Ra02 白血病抑制因子受体(LIFR)多克隆抗体 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl574Hu02 层粘连蛋白α1(LAMα1)多克隆抗体 Polyclonal Antibody to Laminin Alpha 1 (LAMa1)
kl601Mu02 髓过氧化物酶(MPO)多克隆抗体 Polyclonal Antibody to Myeloperoxidase (MPO)
kl615Mu03 纤溶抑制因子(TAFI)多克隆抗体 Polyclonal Antibody to Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
kl626Ra02 胱天蛋白酶3(CASP3)多克隆抗体 Polyclonal Antibody to Caskle 3 (CASP3)
kl672Hu02 Slit同源物2(Slit2)多克隆抗体 Polyclonal Antibody to Slit Homolog 2 (Slit2)
kl692Mu02 神经纤维网蛋白1(NRP1)多克隆抗体 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl692Mu03 神经纤维网蛋白1(NRP1)多克隆抗体 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl692Mu04 神经纤维网蛋白1(NRP1)多克隆抗体 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl711Hu02 肝素酶(HPA)多克隆抗体 Polyclonal Antibody to Heklanase (HPA)
kl775Mu02 己糖激酶1(HK1)多克隆抗体 Polyclonal Antibody to Hexokinase 1 (HK1)
